|
|
|
Corporate Profile: Emergent BioSolutions
| Summary: |
Emergent BioSolutions is focused on the development, manufacture, and commercialization of vaccines and antibody therapeutics for infectious diseases.
|
| Address (HQ): |
2273 Research Boulevard
Suite 400
Rockville, MD 20850 |
| Phone
#'s (HQ): |
| Main |
(301) 795-1800 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
(301) 795-1899 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| EBS |
| Number
of employees: |
| 1400 |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
